Skip to main content
Tianjin Chase Sun Pharmaceutical Co., Ltd. logo

Tianjin Chase Sun Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 300026 ISIN · CNE100000GF1 LEI · 300300WF7FA7N9CEVV43 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,135 across all filing types
Latest filing 2026-05-20 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300026

About Tianjin Chase Sun Pharmaceutical Co., Ltd.

https://www.chasesun.cn

Tianjin Chase Sun Pharmaceutical Co., Ltd. specializes in the research, development, and commercialization of healthcare solutions, with a primary focus on modernized Traditional Chinese Medicine (TCM) and critical care therapeutics. The company’s core portfolio includes TCM formula granules, cardiovascular medications, and the proprietary Xuebijing Injection used in treating systemic inflammatory response syndrome. Beyond pharmaceuticals, the organization maintains a significant presence in the medical device sector, manufacturing diagnostic equipment such as pulse oximeters, nebulizers, and blood pressure monitors. Its operations encompass the entire value chain from active pharmaceutical ingredient (API) synthesis to finished dosage forms. By integrating advanced extraction technologies with clinical research, the company aims to provide standardized, evidence-based treatments for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于完成补选公司第九届董事会独立董事的公告
Board/Management Information Classification · 95% confidence The document is an official announcement by Tianjin Hongri Pharmaceutical Co., Ltd. regarding the completion of the by-election of an independent director to its ninth board. It details the board meeting approvals, nomination process, and confirmation of the new independent director’s qualifications and term. This clearly falls under announcements of changes in the company’s board of directors.
2026-05-20 Chinese
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled “2025年度股东会决议公告” and provides detailed voting results for each proposal at the 2025 annual shareholders’ meeting, including vote counts, percentages, and legal opinion statements. This clearly corresponds to announcing shareholder vote resolutions and results, matching the Declaration of Voting Results & Voting Rights Announcements category.
2026-05-20 Chinese
2025年度股东会法律意见书
Regulatory Filings Classification · 85% confidence The document is a legal opinion letter issued by external counsel (Beijing Jincheng Tongda) on the convening, procedures, and voting results of the 2025 Annual Shareholders’ Meeting of Tianjin Hongri Pharmaceutical Co., Ltd. It is not the AGM notice itself, nor a presentation or the actual report (e.g., 10-K, IR), and it is not a proxy solicitation statement in its entirety. It primarily serves as a compliance/legal review document that must be disclosed, and does not neatly fit any specific category other than a general regulatory/compliance filing. Therefore, it falls under the Regulatory Filings (RNS) fallback category.
2026-05-20 Chinese
关于举行2025年度网上业绩说明会的公告
Regulatory Filings
2026-05-08 Chinese
关于召开2025年度股东会的提示性公告
Regulatory Filings
2026-05-08 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "天津红日药业股份有限公司2025 年年度报告全文" which translates to "Tianjin Chase Sun Pharmaceutical Co., Ltd. 2025 Annual Report Full Text." It contains detailed sections including company overview, financial data, management discussion and analysis, governance, and financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes audited financial data, management analysis, and detailed business descriptions, consistent with an official annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K).
2026-04-20 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.